Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia

Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia

We compared the prostate specific antigen (PSA) levels in benign prostatic hyperplasia (BPH) patients with antiandrogen chlormadinone acetate (CMA) or allylestrenol (AE) before and during the treatment. We also investigated the serial change of PSA levels before, during and after discontinuation of...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 46(2000), 9 vom: 14. Sept., Seite 605-7
1. Verfasser: Noguchi, K (VerfasserIn)
Weitere Verfasser: Uemura, H, Takeda, M, Sekiguchi, Y, Ogawa, K, Hosaka, M
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2000
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Androgen Antagonists Progesterone Congeners Chlormadinone Acetate 0SY050L61N Prostate-Specific Antigen EC 3.4.21.77 Allylestrenol I47VB5DZ8O